Michigan Community Vna in Bingham Farms, MI - Home Health Agency

Michigan Community Vna is a medicare certified home health care agency in Bingham Farms, Michigan. It is located in Bingham Farms at 30800 Telegraph Rd, Suite 1728, Bingham Farms, Michigan 48025. You can reach out to the office of Michigan Community Vna via phone at (800) 882-5720. Michigan Community Vna provide healthcare services in Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide. It has the following ownership type - Proprietary.

Michigan Community Vna is certified by CMS (Centers for Medicare & Medicaid Services) and participates in medicare program. This means if you are part of medicare program, you may consider this home health facility for your medical needs. The medicare CCN number for Michigan Community Vna is 237016 and it was first certified by CMS in 1966 (58 years certified).

Contact Information

Michigan Community Vna
30800 Telegraph Rd, Suite 1728, Bingham Farms, Michigan 48025
(800) 882-5720


Home Healthcare Agency Profile

NameMichigan Community Vna
Location30800 Telegraph Rd, Suite 1728, Bingham Farms, Michigan
Certified ByMedicare
Services OfferedNursing Care
Physical Therapy
Occupational Therapy
Speech Pathology
Medical Social Services
Home Health Aide
Medicare ID237016
Ownership TypeProprietary
Service Area Zip Codes48005, 48009, 48015, 48017, 48021, 48025, 48026, 48030, 48033, 48034, 48035, 48036, 48038, 48042, 48043, 48044, 48045, 48047, 48050, 48051, 48062, 48065, 48066, 48067, 48071, 48072, 48073, 48075, 48076, 48080, 48081, 48082, 48083, 48084, 48085, 48088, 48089, 48091, 48092, 48093, 48094, 48098, 48101, 48103, 48111, 48114, 48116, 48120, 48122, 48124, 48125, 48126, 48127, 48128, 48134, 48135, 48141, 48146, 48150, 48152, 48154, 48165, 48167, 48168, 48170, 48174, 48178, 48180, 48183, 48184, 48185, 48186, 48187, 48188, 48189, 48193, 48195, 48197, 48198, 48201, 48202, 48203, 48204, 48205, 48206, 48207, 48208, 48209, 48210, 48211, 48212, 48213, 48214, 48215, 48216, 48218, 48219, 48220, 48221, 48223, 48224, 48225, 48227, 48228, 48230, 48234, 48235, 48236, 48237, 48238, 48239, 48240, 48301, 48302, 48304, 48306, 48307, 48309, 48310, 48312, 48313, 48314, 48315, 48316, 48317, 48322, 48323, 48324, 48326, 48327, 48328, 48329, 48331, 48334, 48335, 48336, 48340, 48341, 48342, 48346, 48357, 48359, 48362, 48363, 48374, 48375, 48377, 48381, 48382, 48383, 48386, 48390, 48414, 48418, 48429, 48430, 48438, 48439, 48446, 48451, 48476, 48504, 48505, 48507, 48532, 48808, 48813, 48817, 48819, 48820, 48821, 48823, 48827, 48831, 48835, 48836, 48837, 48840, 48842, 48843, 48844, 48848, 48853, 48854, 48855, 48857, 48861, 48864, 48866, 48867, 48872, 48875, 48879, 48890, 48892, 48894, 48895, 48906, 48910, 48911, 48912, 48915, 48917, 48933, 49073, 49096, 49201, 49202, 49203, 49246, 49251, 49264, 49277, 49284

NPI for Michigan Community Vna:

Home Healthcare Agencies may have multiple NPI numbers. We have found possible NPI number/s associated with Michigan Community Vna from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1699010553
Organization NameMICHIGAN COMMUNITY VNA, LLC
Doing Business AsMICHIGAN COMMUNITY VNA
Address30800 Telegraph Rd., Suite 1728, Bingham Farms, MI 48025
Phone Number248-967-1440

News Archive

Air pollution associated with increased risk of deaths in Canada

Air pollution - even at levels below national and international air quality guidelines - is associated with an increased risk of deaths in Canada, according to new UBC research.

Updated clinical data of Calistoga Pharmaceuticals' delta selective PI3K inhibitor presented

Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced updated clinical data on CAL-101, the Company's oral, delta selective PI3K inhibitor, presented during two oral presentations at the 51st American Society of Hematology Annual Meeting in New Orleans.

New molecular sensor technique for cancer therapy detects lactate levels in individual cells

Cancer cells break down sugars and produce the metabolic acid lactate at a much higher rate than normal cells. This phenomenon provides a telltale sign that cancer is present, via diagnostics such as PET scans, and possibly offers an avenue for novel cancer therapies.

Diabetes Research Institute to receive JDRF-HCT grant for islet encapsulation study

JDRF, in collaboration with The Leona M. and Harry B. Helmsley Charitable Trust (HCT), announced today that it has finalized a grant in the area of islet cell encapsulation to Dr. Camillo Ricordi, M.D. and a team of investigators at the Diabetes Research Institute (DRI), based at the University of Miami (FL).

ZIOPHARM receives European patent allowance for palifosfamide to treat cancer

ZIOPHARM Oncology, Inc. announced today that it has received an allowance from the European Patent Office for Patent Application No. 05 821 125.1, entitled "Salts of Isophosphoramide mustard and analogs thereof as anti-tumor agents" with claims directed to pharmaceutical compositions of a novel DNA cross-linker, including palifosfamide and their use in treating cancer.

Read more Medical News

› Verified 4 days ago

Quality Ratings:

Michigan Community Vna is "Medicare-certified" which means that this home health agency is approved by Medicare and meets certain federal health and safety requirements, however, home health agencies may vary in the quality of care and services they provide to their patients. The quality ratings gives you an indication of the care Michigan Community Vna give to their patients incomparison to other home health agencies. This quality rating is based on process quality measures and patient outcome measures survey conducted by CMS.

Quality Rating:

News Archive

Air pollution associated with increased risk of deaths in Canada

Air pollution - even at levels below national and international air quality guidelines - is associated with an increased risk of deaths in Canada, according to new UBC research.

Updated clinical data of Calistoga Pharmaceuticals' delta selective PI3K inhibitor presented

Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced updated clinical data on CAL-101, the Company's oral, delta selective PI3K inhibitor, presented during two oral presentations at the 51st American Society of Hematology Annual Meeting in New Orleans.

New molecular sensor technique for cancer therapy detects lactate levels in individual cells

Cancer cells break down sugars and produce the metabolic acid lactate at a much higher rate than normal cells. This phenomenon provides a telltale sign that cancer is present, via diagnostics such as PET scans, and possibly offers an avenue for novel cancer therapies.

Diabetes Research Institute to receive JDRF-HCT grant for islet encapsulation study

JDRF, in collaboration with The Leona M. and Harry B. Helmsley Charitable Trust (HCT), announced today that it has finalized a grant in the area of islet cell encapsulation to Dr. Camillo Ricordi, M.D. and a team of investigators at the Diabetes Research Institute (DRI), based at the University of Miami (FL).

ZIOPHARM receives European patent allowance for palifosfamide to treat cancer

ZIOPHARM Oncology, Inc. announced today that it has received an allowance from the European Patent Office for Patent Application No. 05 821 125.1, entitled "Salts of Isophosphoramide mustard and analogs thereof as anti-tumor agents" with claims directed to pharmaceutical compositions of a novel DNA cross-linker, including palifosfamide and their use in treating cancer.

Read more Medical News

› Verified 4 days ago

Process Quality Measures:

The below quality measures show how often Michigan Community Vna used best practices when caring for its patients (process measures). Michigan Community Vna quality data is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Quality MeasureProviderNational Avg.
How often the home health team began their patients’ care in a timely manner99.695.7
How often the home health team taught patients (or their family caregivers) about their drugs98.998.6
How often the home health team checked patients’ risk of falling10099.6
How often the home health team checked patients for depression99.997.4
How often the home health team made sure that their patients have received a flu shot for the current flu season.81.578.7
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot).84.482.2
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care99.296.4

News Archive

Air pollution associated with increased risk of deaths in Canada

Air pollution - even at levels below national and international air quality guidelines - is associated with an increased risk of deaths in Canada, according to new UBC research.

Updated clinical data of Calistoga Pharmaceuticals' delta selective PI3K inhibitor presented

Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced updated clinical data on CAL-101, the Company's oral, delta selective PI3K inhibitor, presented during two oral presentations at the 51st American Society of Hematology Annual Meeting in New Orleans.

New molecular sensor technique for cancer therapy detects lactate levels in individual cells

Cancer cells break down sugars and produce the metabolic acid lactate at a much higher rate than normal cells. This phenomenon provides a telltale sign that cancer is present, via diagnostics such as PET scans, and possibly offers an avenue for novel cancer therapies.

Diabetes Research Institute to receive JDRF-HCT grant for islet encapsulation study

JDRF, in collaboration with The Leona M. and Harry B. Helmsley Charitable Trust (HCT), announced today that it has finalized a grant in the area of islet cell encapsulation to Dr. Camillo Ricordi, M.D. and a team of investigators at the Diabetes Research Institute (DRI), based at the University of Miami (FL).

ZIOPHARM receives European patent allowance for palifosfamide to treat cancer

ZIOPHARM Oncology, Inc. announced today that it has received an allowance from the European Patent Office for Patent Application No. 05 821 125.1, entitled "Salts of Isophosphoramide mustard and analogs thereof as anti-tumor agents" with claims directed to pharmaceutical compositions of a novel DNA cross-linker, including palifosfamide and their use in treating cancer.

Read more Medical News

› Verified 4 days ago

Patient Outcome Quality Measures:

The below quality measures show whether patients with Michigan Community Vna improved in certain important areas of care (patient outcome). Michigan Community Vna quality data is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Quality MeasureProviderNational Avg.
How often patients got better at walking or moving around79.779.6
How often patients got better at getting in and out of bed80.881.1
How often patients got better at bathing83.582.3
How often patients’ breathing improved84.682.8
How often patients’ wounds improved or healed after an operation72.392.3
How often patients got better at taking their drugs correctly by mouth74.675
How often home health patients had to be admitted to the hospital15.815.4
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted10.213
How often physician-recommended actions to address medication issues were completely timely98.994

News Archive

Air pollution associated with increased risk of deaths in Canada

Air pollution - even at levels below national and international air quality guidelines - is associated with an increased risk of deaths in Canada, according to new UBC research.

Updated clinical data of Calistoga Pharmaceuticals' delta selective PI3K inhibitor presented

Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced updated clinical data on CAL-101, the Company's oral, delta selective PI3K inhibitor, presented during two oral presentations at the 51st American Society of Hematology Annual Meeting in New Orleans.

New molecular sensor technique for cancer therapy detects lactate levels in individual cells

Cancer cells break down sugars and produce the metabolic acid lactate at a much higher rate than normal cells. This phenomenon provides a telltale sign that cancer is present, via diagnostics such as PET scans, and possibly offers an avenue for novel cancer therapies.

Diabetes Research Institute to receive JDRF-HCT grant for islet encapsulation study

JDRF, in collaboration with The Leona M. and Harry B. Helmsley Charitable Trust (HCT), announced today that it has finalized a grant in the area of islet cell encapsulation to Dr. Camillo Ricordi, M.D. and a team of investigators at the Diabetes Research Institute (DRI), based at the University of Miami (FL).

ZIOPHARM receives European patent allowance for palifosfamide to treat cancer

ZIOPHARM Oncology, Inc. announced today that it has received an allowance from the European Patent Office for Patent Application No. 05 821 125.1, entitled "Salts of Isophosphoramide mustard and analogs thereof as anti-tumor agents" with claims directed to pharmaceutical compositions of a novel DNA cross-linker, including palifosfamide and their use in treating cancer.

Read more Medical News

› Verified 4 days ago

Patients' Survey and Ratings:

The patient experience of care survey collects patient (or their family or friend's) feedback about topics for which the patient is the best source of information. When choosing a home health agency, patients can use this information to find out what other patients thought about the care given by a certain home health agency. The total number of patients who responded in this survey for Michigan Community Vna are 466.
Question Type:Rating by Patients
Health team gave care in a professional way
Health team communicated well with them
Health team discussed medicines, pain, and home safety
How patients rated overall care from agency

News Archive

Air pollution associated with increased risk of deaths in Canada

Air pollution - even at levels below national and international air quality guidelines - is associated with an increased risk of deaths in Canada, according to new UBC research.

Updated clinical data of Calistoga Pharmaceuticals' delta selective PI3K inhibitor presented

Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced updated clinical data on CAL-101, the Company's oral, delta selective PI3K inhibitor, presented during two oral presentations at the 51st American Society of Hematology Annual Meeting in New Orleans.

New molecular sensor technique for cancer therapy detects lactate levels in individual cells

Cancer cells break down sugars and produce the metabolic acid lactate at a much higher rate than normal cells. This phenomenon provides a telltale sign that cancer is present, via diagnostics such as PET scans, and possibly offers an avenue for novel cancer therapies.

Diabetes Research Institute to receive JDRF-HCT grant for islet encapsulation study

JDRF, in collaboration with The Leona M. and Harry B. Helmsley Charitable Trust (HCT), announced today that it has finalized a grant in the area of islet cell encapsulation to Dr. Camillo Ricordi, M.D. and a team of investigators at the Diabetes Research Institute (DRI), based at the University of Miami (FL).

ZIOPHARM receives European patent allowance for palifosfamide to treat cancer

ZIOPHARM Oncology, Inc. announced today that it has received an allowance from the European Patent Office for Patent Application No. 05 821 125.1, entitled "Salts of Isophosphoramide mustard and analogs thereof as anti-tumor agents" with claims directed to pharmaceutical compositions of a novel DNA cross-linker, including palifosfamide and their use in treating cancer.

Read more Medical News

› Verified 4 days ago

The patient survey data of Michigan Community Vna is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience MeasureProviderNational Avg.
Percent of patients who reported that their home health team gave care in a professional way8888
Percent of patients who reported that their home health team communicated well with them8585
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them8283
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest)8284
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family7378

News Archive

Air pollution associated with increased risk of deaths in Canada

Air pollution - even at levels below national and international air quality guidelines - is associated with an increased risk of deaths in Canada, according to new UBC research.

Updated clinical data of Calistoga Pharmaceuticals' delta selective PI3K inhibitor presented

Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced updated clinical data on CAL-101, the Company's oral, delta selective PI3K inhibitor, presented during two oral presentations at the 51st American Society of Hematology Annual Meeting in New Orleans.

New molecular sensor technique for cancer therapy detects lactate levels in individual cells

Cancer cells break down sugars and produce the metabolic acid lactate at a much higher rate than normal cells. This phenomenon provides a telltale sign that cancer is present, via diagnostics such as PET scans, and possibly offers an avenue for novel cancer therapies.

Diabetes Research Institute to receive JDRF-HCT grant for islet encapsulation study

JDRF, in collaboration with The Leona M. and Harry B. Helmsley Charitable Trust (HCT), announced today that it has finalized a grant in the area of islet cell encapsulation to Dr. Camillo Ricordi, M.D. and a team of investigators at the Diabetes Research Institute (DRI), based at the University of Miami (FL).

ZIOPHARM receives European patent allowance for palifosfamide to treat cancer

ZIOPHARM Oncology, Inc. announced today that it has received an allowance from the European Patent Office for Patent Application No. 05 821 125.1, entitled "Salts of Isophosphoramide mustard and analogs thereof as anti-tumor agents" with claims directed to pharmaceutical compositions of a novel DNA cross-linker, including palifosfamide and their use in treating cancer.

Read more News

› Verified 4 days ago

Home Healthcare Agencies in Bingham Farms, MI

Michigan Community Vna
Location: 30800 Telegraph Rd, Suite 1728, Bingham Farms, Michigan 48025
Ratings:

Phone: (800) 882-5720    
Professional Home Care
Location: 30600 Telegraph, Suite 3140, Bingham Farms, Michigan 48025
Ratings:

Phone: (313) 294-9220    
Optimal Care
Location: 30600 Telegraph Road, Suite 3275, Bingham Farms, Michigan 48025
Ratings:

Phone: (248) 723-9613    
John Paul Home Health Care
Location: 30800 Telegraph Rd #3700, Bingham Farms, Michigan 48025
Ratings:

Phone: (248) 731-7457    
Supportive Home Health Care
Location: 30100 Telegraph Rd, Suite 478, Bingham Farms, Michigan 48025
Ratings:

Phone: (248) 291-5806    
Elara Caring
Location: 30400 Telegraph Rd, Suite 334, Bingham Farms, Michigan 48025
Ratings:

Phone: (734) 525-4830    

Home Health Care

Home health care is a wide range of health care services that can be given in your home for an illness or injury. Home health care is usually less expensive, more convenient, and just as effective as care you get in a hospital or skilled nursing facility (SNF). The goal of home health care is to treat an illness or injury. Home health care helps you get better, regain your independence, and become as self-sufficient as possible.

Home Healthcare Agency Compare

Home Health Compare has information about the quality of care provided by "Medicare-certified" home health agencies throughout the nation. "Medicare-certified" means the home health agency is approved by Medicare and meets certain federal health and safety requirements. Home Health Compare can help you or your family or friends choose a quality home health agency that has the skilled home health services you need.

Home Health Compare was created through the efforts of the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services (DHHS).

NOTE: Medicare won't cover home health services provided by a home health agency that hasn't been Medicare-certified.

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.